ArticleJAAD case reports2022

A diagnostic dilemma: Atypical melanocytic lesions arising in the setting of treatment with the BRAF inhibitor, vemurafenib.

Mary Clark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.